ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

VOR Vor Biopharma Inc

1,72
0,005 (0,29%)
Zuletzt aktualisiert: 18:23:36
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Vor Biopharma Inc VOR NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,005 0,29% 1,72 18:23:36
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,72 1,68 1,73 1,715
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
09.5.202422:05GLOBEVor Bio Reports First Quarter 2024 Financial Results and..
09.5.202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.5.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.5.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.5.202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
03.5.202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
02.5.202422:01GLOBEVor Bio Appoints Accomplished Oncology and Cancer..
01.4.202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
20.3.202421:05GLOBEVor Bio Reports Fourth Quarter and Full Year 2023 Financial..
05.3.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.3.202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
04.3.202414:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
14.2.202422:08EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08.2.202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202423:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.2.202414:00GLOBEVor Bio to Participate in the Oppenheimer 34th Annual..
02.2.202422:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01.2.202401:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.2.202401:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.1.202422:01GLOBEVor Bio Doses First AML Patient with VCAR33 (ALLO) and..
05.1.202423:03EDGAR2Form 8-K - Current report
21.12.202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
01.12.202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
27.11.202314:00GLOBEVor Bio to Participate in the JMP Securities Hematology and..
09.11.202322:01GLOBEVor Bio Presents Positive Data Update on Trem-cel at HSCT²..
08.11.202322:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202322:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.11.202322:05GLOBEVor Bio Reports Third Quarter 2023 Financial Results and..
07.11.202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03.11.202321:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
03.11.202313:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
02.11.202314:10EDGAR2Form 8-K - Current report
02.11.202314:01GLOBEMultiple Clinical and Preclinical Presentations at ASH..
03.10.202322:01GLOBEVor Bio Reports Inducement Grant Under Nasdaq Listing Rule..
25.9.202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
06.9.202322:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.9.202322:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30.8.202322:51EDGAR2Form S-8 - Securities to be offered to employees in employee..
30.8.202314:00GLOBEVor Bio to Participate in Upcoming Investor Conferences
10.8.202322:05GLOBEVor Bio Reports Second Quarter 2023 Financial Results and..
10.8.202322:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.8.202322:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01.8.202314:00GLOBEVor Bio to Participate in the Wedbush PacGrow Healthcare..
09.6.202313:30GLOBESuccessful Primary Engraftment of Trem-cel in First Five AML..
05.6.202314:00GLOBEVor Bio to Participate in the Goldman Sachs Healthcare..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock